Movatterモバイル変換


[0]ホーム

URL:


PhilPapersPhilPeoplePhilArchivePhilEventsPhilJobs
Order:

1 filter applied
  1.  79
    The Impact of Web 2.0 on the Doctor-Patient Relationship.Bernard Lo &Lindsay Parham -2010 -Journal of Law, Medicine and Ethics 38 (1):17-26.
    Web 2.0 innovations may enhance informed patient decision-making, but also raise ethical concerns about inaccurate or misleading information, damage to the doctor-patient relationship, privacy and confidentiality, and health disparities. To increase the benefits and decrease the risks of these innovations, we recommend steps to help patients assess the quality of health information on the Internet; promote constructive doctor-patient communication about new information technologies; and set standards for privacy and data security in patient-controlled health records and for point-of-service advertising.
    Direct download(2 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  2.  81
    Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo &Lindsay Parham -2010 -Journal of Law, Medicine and Ethics 38 (2):257-266.
    Stem cells derived from pluripotent cells offer the hope of new treatments for diseases for which current therapy is inadequate. Clinical trials are essential in developing effective and safe stem cell therapies and fulfilling this promise. However, such clinical trials raise ethical issues that are more complex than those raised in clinical trials using drugs, cord blood stem cells, or adult stem cells. Several clinical trials are now being carried out with stem cells derived from pluripotent cells, and many more (...) can be expected in light of the rapid scientific progress in the field.Degenerative neurological diseases are desirable targets for stem cell clinical trials. The FDA has approved Phase 1 clinical trials of neural stem cell transplantation for Batten Disease, Pelizaeus-Merzbacher Disease, and spinal cord injury. In Parkinson Disease, stem cell transplantation could correct the primary pathophysiological defect — inadequate levels of the neurotransmitter dopamine. Current treatment is unsatisfactory in late-stage PD. (shrink)
    Direct download(3 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  3.  43
    The US model for oversight of human stem cell research.Lindsay Parham &Bernard Lo -2010 - In John Elliott, W. Calvin Ho & Sylvia S. N. Lim,Bioethics in Singapore: The Ethical Microcosm. World Scientific. pp. 109.
    Direct download  
     
    Export citation  
     
    Bookmark  
Export
Limit to items.
Filters





Configure languageshere.Sign in to use this feature.

Viewing options


Open Category Editor
Off-campus access
Using PhilPapers from home?

Create an account to enable off-campus access through your institution's proxy server or OpenAthens.


[8]ページ先頭

©2009-2025 Movatter.jp